World's Best Scientists 2026 revealed!
Award Badge
Immunology
Israel
2026

D-Index & Metrics

Discipline name D-Index World Ranking Current World Ranking National Ranking Current National Ranking Publications Citations
Immunology 89 1134 1027 8 7 414 22867
Medicine 88 13352 12567 32 28 414 22620

Ruth Arnon publications per year

The chart shows the history of publications by Ruth Arnon between 1960 and 2024, highlighting the no. of papers published in each year and offering an overview of the publication velocity of this scholar. Ruth Arnon published across 65 years, from 1960 to 2024, averaging 6.7 papers a year. Output peaked at 15 publications in 1975. 3 of the 435 publications appeared in the last two years.

No. of publications
5 10 15
Bar chart. Horizontal axis: year, 1960 to 2024. Vertical axis: number of publications, 0 to 15. Peak 15 publications in 1975. 1960: 6 publications 1961: 0 publications 1962: 1 publication 1963: 3 publications 1964: 0 publications 1965: 4 publications 1966: 3 publications 1967: 7 publications 1968: 5 publications 1969: 4 publications 1970: 6 publications 1971: 8 publications 1972: 4 publications 1973: 11 publications 1974: 13 publications 1975: 15 publications 1976: 7 publications 1977: 11 publications 1978: 11 publications 1979: 7 publications 1980: 7 publications 1981: 6 publications 1982: 12 publications 1983: 11 publications 1984: 14 publications 1985: 14 publications 1986: 13 publications 1987: 6 publications 1988: 8 publications 1989: 11 publications 1990: 6 publications 1991: 12 publications 1992: 12 publications 1993: 9 publications 1994: 6 publications 1995: 11 publications 1996: 12 publications 1997: 14 publications 1998: 12 publications 1999: 12 publications 2000: 3 publications 2001: 5 publications 2002: 5 publications 2003: 5 publications 2004: 8 publications 2005: 6 publications 2006: 8 publications 2007: 5 publications 2008: 4 publications 2009: 6 publications 2010: 3 publications 2011: 4 publications 2012: 8 publications 2013: 3 publications 2014: 5 publications 2015: 3 publications 2016: 6 publications 2017: 2 publications 2018: 2 publications 2019: 1 publication 2020: 2 publications 2021: 3 publications 2022: 1 publication 2023: 2 publications 2024: 1 publication
1960 2024

435 publications in total across all disciplines

View publications per year as a table
Ruth Arnon: publications per year, 1960 to 2024
Year Publications
1960 6
1961 0
1962 1
1963 3
1964 0
1965 4
1966 3
1967 7
1968 5
1969 4
1970 6
1971 8
1972 4
1973 11
1974 13
1975 15
1976 7
1977 11
1978 11
1979 7
1980 7
1981 6
1982 12
1983 11
1984 14
1985 14
1986 13
1987 6
1988 8
1989 11
1990 6
1991 12
1992 12
1993 9
1994 6
1995 11
1996 12
1997 14
1998 12
1999 12
2000 3
2001 5
2002 5
2003 5
2004 8
2005 6
2006 8
2007 5
2008 4
2009 6
2010 3
2011 4
2012 8
2013 3
2014 5
2015 3
2016 6
2017 2
2018 2
2019 1
2020 2
2021 3
2022 1
2023 2
2024 1
Total 435
Download as CSV

Ruth Arnon publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Ruth Arnon sits on this spectrum.

No. of scientists
50 100 150
Bar chart with 76 bars. Horizontal axis: publications, 62–71 to 807+. Vertical axis: number of scientists, 0 to 189. Most scientists, 189, have 152–161 publications. The last bar groups every scientist with 807 publications or more. The highlighted bar, 412–421 publications, is where this scientist sits. 62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 69 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientist 807+ publications: 100 scientists
62–71 publications 807+

This scientist: 414 publications — 82nd percentile

82% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

View publications distribution as a table
Number of Immunology scientists by publication count, Research.com 2026 ranking edition. Based on 4,929 ranked scientists.
Publications Scientists This scientist
62–71 9
72–81 23
82–91 40
92–101 72
102–111 86
112–121 108
122–131 150
132–141 160
142–151 159
152–161 189
162–171 166
172–181 181
182–191 188
192–201 187
202–211 178
212–221 158
222–231 168
232–241 159
242–251 160
252–261 148
262–271 116
272–281 125
282–291 115
292–301 111
302–311 95
312–321 97
322–331 97
332–341 99
342–351 96
352–361 69
362–371 76
372–381 71
382–391 71
392–401 62
402–411 54
412–421 41 414
422–431 63
432–441 53
442–451 31
452–461 42
462–471 40
472–481 29
482–491 34
492–501 30
502–511 23
512–521 41
522–531 29
532–541 28
542–551 16
552–561 18
562–571 18
572–581 17
582–591 17
592–601 17
602–611 19
612–621 13
622–631 12
632–641 11
642–651 16
652–661 9
662–671 5
672–681 13
682–691 12
692–701 6
702–711 6
712–721 9
722–731 9
732–741 6
742–751 11
752–761 10
762–771 7
772–781 12
782–791 7
792–801 5
802–806 1
807+ 100
Download as CSV

Ruth Arnon D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Ruth Arnon sits on this spectrum.

No. of scientists
50 100 150 200
Bar chart with 60 bars. Horizontal axis: D-Index, 40–41 to 157+. Vertical axis: number of scientists, 0 to 201. Most scientists, 201, have 58–59 D-Index. The last bar groups every scientist with 157 D-Index or more. The highlighted bar, 88–89 D-Index, is where this scientist sits. 40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 163 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40–41 D-Index 157+

This scientist: 89 D-Index — 78th percentile

78% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

View D-Index distribution as a table
Number of Immunology scientists by D-index, Research.com 2026 ranking edition. Based on 4,929 ranked scientists.
D-Index Scientists This scientist
40–41 28
42–43 91
44–45 157
46–47 192
48–49 175
50–51 188
52–53 177
54–55 155
56–57 194
58–59 201
60–61 197
62–63 201
64–65 173
66–67 167
68–69 172
70–71 199
72–73 184
74–75 133
76–77 163
78–79 127
80–81 121
82–83 125
84–85 121
86–87 102
88–89 96 89
90–91 75
92–93 72
94–95 74
96–97 66
98–99 68
100–101 49
102–103 60
104–105 54
106–107 36
108–109 23
110–111 52
112–113 41
114–115 34
116–117 25
118–119 28
120–121 11
122–123 20
124–125 27
126–127 19
128–129 20
130–131 16
132–133 17
134–135 14
136–137 15
138–139 9
140–141 11
142–143 9
144–145 9
146–147 7
148–149 7
150–151 7
152–153 5
154–155 8
156 6
157+ 96
Download as CSV

Research.com Recognitions

  • 2026 - Research.com Immunology in Israel Leader Award
  • 2025 - Research.com Immunology in Israel Leader Award
  • 2023 - Research.com Immunology in Israel Leader Award
  • 2022 - Research.com Immunology in Israel Leader Award
  • 2017 - Fellow of the American Academy of Arts and Sciences
  • 1979 - Robert Koch Prize
  • Member of the European Academy of Sciences and Arts
  • Member of the European Academy of Sciences and Arts
  • Member of the European Academy of Sciences and Arts
  • Member of the European Academy of Sciences and Arts
  • Member of the European Academy of Sciences and Arts
  • Member of the European Academy of Sciences and Arts

Overview

Ruth Arnon is affiliated with the Weizmann Institute of Science in Israel and has contributed extensively to the field of medicine with a focus on multiple sclerosis and neurodegenerative diseases. Their research spans various subfields including pathology and forensic medicine, immunology, physiology, molecular biology, and neurology.

The scientist's work addresses several major topics including:

  • Multiple Sclerosis Research Studies
  • Neurogenesis and neuroplasticity mechanisms
  • Immunotherapy and Immune Responses
  • Alzheimer's disease research and treatments
  • Cardiac Fibrosis and Remodeling
  • Neuroinflammation and Neurodegeneration Mechanisms
  • Peripheral Neuropathies and Disorders

A selection of recent publications includes:

  • Astrocytes in Multiple Sclerosis-Essential Constituents with Diverse Multifaceted Functions, 2021, International Journal of Molecular Sciences
  • Neuroprotective Effect of Glatiramer Acetate on Neurofilament Light Chain Leakage and Glutamate Excess in an Animal Model of Multiple Sclerosis, 2021, International Journal of Molecular Sciences
  • Glatiramer acetate increases T- and B -regulatory cells and decreases granulocyte-macrophage colony-stimulating factor (GM-CSF) in an animal model of multiple sclerosis, 2020, Journal of Neuroimmunology
  • Titration of myelin oligodendrocyte glycoprotein (MOG) - Induced experimental autoimmune encephalomyelitis (EAE) model, 2020, Journal of Neuroscience Methods
  • Peptide Interference with APP and Tau Association: Relevance to Alzheimer's Disease Amelioration, 2020, International Journal of Molecular Sciences

Frequent publication venues for Ruth Arnon include:

  • International Journal of Molecular Sciences
  • Journal of Neuroimmunology
  • Journal of Neuroscience Methods
  • Nature Cardiovascular Research
  • European Journal of Immunology

Collaborative research is a part of their career, notably working alongside researchers such as Rina Aharoni, Raya Eilam, Ruth Maron, Michael Tsoory, and Meir Wilchek. These partnerships have contributed to multiple publications and cross-disciplinary studies.

Recognition in the scientific community is indicated by several awards, including:

  • Fellow of the American Academy of Arts and Sciences, 2017
  • Robert Koch Prize, 1979
  • Member of the European Academy of Sciences and Arts

Best Publications

  • Suppression of experimental allergic encephalomyelitis by a synthetic polypeptide.

    Dvora Teitelbaum;A. Meshorer;T. Hirshfeld;Ruth Arnon

  • A Pilot Trial of Cop 1 in Exacerbating–Remitting Multiple Sclerosis

    Bornstein Mb;Miller A;Slagle S;Weitzman M

  • Copolymer 1 induces T cells of the T helper type 2 that crossreact with myelin basic protein and suppress experimental autoimmune encephalomyelitis

    Rina Aharoni;Dvora Teitelbaum;Michael Sela;Ruth Arnon

  • The Covalent Binding of Daunomycin and Adriamycin to Antibodies, with Retention of Both Drug and Antibody Activities

    Esther Hurwitz;Ronald Levy;Ruth Maron;Meir Wilchek

  • Direct binding of myelin basic protein and synthetic copolymer 1 to class II major histocompatibility complex molecules on living antigen-presenting cells--specificity and promiscuity

    Masha Fridkis-Hareli;Dvora Teitelbaum;Evgeny Gurevich;Israel Pecht

  • Glatiramer acetate-specific T cells in the brain express T helper 2/3 cytokines and brain-derived neurotrophic factor in situ

    Rina Aharoni;Basak Kayhan;Raya Eilam;Michael Sela

  • Monoclonal and polyclonal antibodies against acetaldehyde-containing epitopes in acetaldehyde-protein adducts.

    Yedy Israel;Esther Hurwitz;Onni Niemela;Ruth Arnon

  • Specific Th2 cells accumulate in the central nervous system of mice protected against experimental autoimmune encephalomyelitis by copolymer 1.

    Rina Aharoni;Dvora Teitelbaum;Orith Leitner;Asher Meshorer

  • Studies on the chemical basis of the antigenicity of proteins. 5. Synthesis, characterization and immunogenicity of some multichain and linear polypeptides containing tyrosine.

    M. Sela;Sara Fuchs;Ruth Arnon

  • The immunomodulator glatiramer acetate augments the expression of neurotrophic factors in brains of experimental autoimmune encephalomyelitis mice

    Rina Aharoni;Raya Eilam;Hagit Domev;Galya Labunskay

  • Bystander suppression of experimental autoimmune encephalomyelitis by T cell lines and clones of the Th2 type induced by copolymer 1

    Rina Aharoni;Dvora Teitelbaum;Michael Sela;Ruth Arnon

  • Mechanism of action of glatiramer acetate in multiple sclerosis and its potential for the development of new applications.

    Ruth Arnon;Rina Aharoni

  • A placebo‐controlled, double‐blind, randomized, two‐center, pilot trial of Cop 1 in chronic progressive multiple sclerosis

    M. B. Bornstein;A. Miller;A. Miller;S. Slagle;M. Weitzman

  • Copolymer 1 acts against the immunodominant epitope 82–100 of myelin basic protein by T cell receptor antagonism in addition to major histocompatibility complex blocking

    Rina Aharoni;Dvora Teitelbaum;Ruth Arnon;Michael Sela

  • Anti-influenza response achieved by immunization with a synthetic conjugate

    Gunhild M. Muller;Michal Shapira;Ruth Arnon

  • A DNA aptamer prevents influenza infection by blocking the receptor binding region of the viral hemagglutinin.

    Sung Ho Jeon;Basak Kayhan;Tamar Ben-Yedidia;Ruth Arnon

  • Copolymer 1 inhibits chronic relapsing experimental allergic encephalomyelitis induced by proteolipid protein (PLP) peptides in mice and interferes with PLP-specific T cell responses

    Dvora Teitelbaum;Masha Fridkis-Hareli;Ruth Arnon;Michael Sela

  • Antibodies reactive with native lysozyme elicited by a completely synthetic antigen.

    Ruth Arnon;Elchanan Maron;Michael Sela;Christian B. Anfinsen

  • Neurogenesis and Neuroprotection Induced by Peripheral Immunomodulatory Treatment of Experimental Autoimmune Encephalomyelitis

    Rina Aharoni;Ruth Arnon;Raya Eilam

  • Suppression by several synthetic polypeptides of experimental allergic encephalomyelitis induced in guinea pigs and rabbits with bovine and human basic encephalitogen

    Dvora Teitelbaum;Cynthia Webb;A. Meshorer;Ruth Arnon

  • With retention of both drug and antibody activities.

    E Hurwitz;R Levy;R Maron;M Wilchek

Frequent Co-Authors

Michael Sela
Michael Sela Weizmann Institute of Science
Meir Wilchek
Meir Wilchek Weizmann Institute of Science
Benjamin Geiger
Benjamin Geiger Weizmann Institute of Science
Francesca Levi-Schaffer
Francesca Levi-Schaffer Hebrew University of Jerusalem
Michal Schwartz
Michal Schwartz Weizmann Institute of Science
Israel Silman
Israel Silman Weizmann Institute of Science
Chaim O. Jacob
Chaim O. Jacob University of Southern California
Israel Pecht
Israel Pecht Weizmann Institute of Science
Ronald Levy
Ronald Levy Stanford University
Louis Chedid
Louis Chedid University of South Florida

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Immunology in the USA opens up diverse career opportunities in healthcare and research. Many students complement their immunology knowledge with nursing qualifications to work closely with patients or within clinical settings.

For those interested in quickly entering the nursing field, exploring the easiest accelerated nursing programs can be a great starting point. These programs offer a fast track for those who already hold a bachelor’s degree and want to become registered nurses swiftly.

If you’re looking for a more direct route into nursing, consider the easy admission LPN programs. Licensed Practical Nurse (LPN) programs generally provide foundational clinical skills needed to support patients, including those with immune-related conditions.

For advanced practice, the easiest FNP program offers Nurse Practitioner education with a family focus, ideal for immunology graduates aiming for leadership in patient care.

Additionally, specialized fields such as psychiatric nursing intersect with immunology research. The best online psychiatric mental health nurse practitioner programs combine clinical expertise with mental health insights, expanding career possibilities.

Best Scientists Citing Ruth Arnon

Trending Scientists

Recently Published Articles